Research Topics
| Milena SantSummaryAffiliation: Istituto Nazionale Tumori Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Stage at diagnosis is a key explanation of differences in breast cancer survival across EuropeMilena Sant
Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milan, Italy
Int J Cancer 106:416-22. 2003..Screening for breast cancer did not seem to affect the survival patterns once stage had been taken into account...
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentaryM Sant
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Ann Oncol 14:v61-118. 2003..The affluence of countries influenced overall cancer survival through the availability of adequate diagnostic and treatment procedures, and screening programmes...
Breast carcinoma survival in Europe and the United StatesMilena Sant
Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Cancer 100:715-22. 2004..Breast carcinoma survival rates were found to be higher in the U.S. than in Europe...
Should we use incidence, survival or mortality to assess breast cancer trends in European women?Milena Sant
Department of Predictive and Preventive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Nat Clin Pract Oncol 3:228-9. 2006
Time trends of breast cancer survival in Europe in relation to incidence and mortalityMilena Sant
Department of Preventive and Predictive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Int J Cancer 119:2417-22. 2006..In Estonia, low and stable survival in the context of increasing incidence and mortality suggests inadequate care...
Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution studyMilena Sant
Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan I 20133, Italy
Eur J Cancer 43:585-92. 2007..Significantly higher than reference HRs in Estonia and Poland suggest inadequacy or unavailability of treatments...
Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian studyMilena Sant
Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Int J Cancer 121:911-4. 2007....
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentaryMilena Sant
Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Eur J Cancer 45:931-91. 2009..For all cancers, 5-year survival conditional to surviving 1-year was higher and varied less with region, than the overall relative survival...
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE projectMilena Sant
Department of Preventive and Predictive Medicine, Unit of Analytical Epidemiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Blood 116:3724-34. 2010..Differences in diagnostic and registration criteria are an important cause of incidence variation; however, different distribution of HM risk factors also contributes. The quality of population-based HM data needs further improvement...
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 studyFranco Berrino
Department of Preventive and Predictive Medicine, Fondazione Istituto Nazionale dei Tumori, Milan, Italy
Lancet Oncol 8:773-83. 2007..This report (EUROCARE-4) presents survival data for eight selected cancer sites and for all cancers combined, diagnosed in adult (aged >/=15 years) Europeans in 1995-99 and followed up until the end of 2003...
Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groupsClaudia Allemani
Epidemiology Unit, Department of Preventive and Predictive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
Cancer 107:352-60. 2006..S. To investigate these differences, the authors compared population-based HD survival in relation to morphologic type among populations in Europe and the U.S...
Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution studyClaudia Allemani
Analytical Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Eur J Cancer 46:1528-36. 2010....
Do pre-diagnostic drinking habits influence breast cancer survival?Claudia Allemani
Department of Preventive and Predictive Medicine, Analytical Epidemiology Unit, Italy
Tumori 97:142-8. 2011..The aim of this study was to investigate the survival of women with breast cancer in relation to pre-diagnostic alcohol intake and other factors known to influence prognosis...
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United StatesMilena Sant
Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I 20133, Milan, Italy
Eur J Cancer 44:579-87. 2008..Interpretation of marked variation in survival with morphology is complicated by classification inconsistencies. The completeness and standardisation of cancer registry morphology data needs to be improved...
Contrasts in cancer prevalence in Connecticut, Iowa, and UtahAndrea Micheli
Unita di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Cancer 95:430-9. 2002..In this study, we estimate and analyze the prevalence of seven major cancers in Connecticut, lowa, and Utah using the tried and tested PREVAL method applied to National Cancer Institute registry data...
Interpreting survival differences and trendsF Berrino
Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Tumori 83:9-16. 1997....
Survival from salivary glands adenoid cystic carcinoma in European populationsLaura Ciccolallo
Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
Oral Oncol 45:669-74. 2009..Improvements in the disease detection in its early stage and international collaborative research should be encouraged...
The advantage of women in cancer survival: an analysis of EUROCARE-4 dataA Micheli
Descriptive Epidemiology and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Eur J Cancer 45:1017-27. 2009....
Life tables for world-wide comparison of relative survival for cancer (CONCORD study)Paolo Baili
Descriptive Epidemiology and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Tumori 94:658-68. 2008....
The ITACARE StudyM Sant
Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Tumori 83:17-24. 1997..Overall mortality decreased during the period, more markedly in the north and among women...
Survival of European children and young adults with cancer diagnosed 1995-2002Gemma Gatta
Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
Eur J Cancer 45:992-1005. 2009..Cancer survival in patients <25 years is poorly documented in Eastern European countries. Complete cancer registration should be a priority for these countries as an essential part of a policy for effective cancer control in Europe...
International collaborations in cancer control and the Third International Cancer Control CongressAndrea Micheli
Descriptive Studies and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
Tumori 95:579-96. 2009..As a consequence, less resources of development aids are allocated to control NCDs including cancer...
European health systems and cancer careA Micheli
Unit of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Ann Oncol 14:v41-60. 2003....
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution studyG Gatta
Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Gut 47:533-8. 2000..Marked differences in population based survival across Europe were found for colorectal cancers diagnosed in 1985-1989...
Cancer survival increases in Europe, but international differences remain wideM Sant
Department of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan, Italy
Eur J Cancer 37:1659-67. 2001..The persisting regional differences suggest there are corresponding differences in the availability of diagnostic and therapeutic facilities, and in the effectiveness of healthcare systems...
Prognostic value of morphology and hormone receptor status in breast cancer - a population-based studyC Allemani
Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milano, Italy
Br J Cancer 91:1263-8. 2004..Morphology and hormone receptor status were confirmed as significant survival predictors in this population-based study, even after adjusting for age and stage at diagnosis...
Differences in stage and therapy for breast cancer across EuropeM Sant
Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Int J Cancer 93:894-901. 2001..These wide differences in breast cancer care across Europe in the early 1990s indicate a need for continual monitoring of past treatments to help ensure application of the most effective protocols...
Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working GroupM Sant
Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Int J Cancer 77:679-83. 1998..Low survival in the United Kingdom may be due to inadequate adherence to consensus treatment guidelines and greater variation in treatment...
Survival for retinoblastoma in EuropeM Sant
Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I-20133, Milan, Italy
Eur J Cancer 37:730-5. 2001..There was statistically significant effect related to the period of diagnosis, with a 50% reduction in the relative risk (RR) for children diagnosed in 1986--1989 compared with those diagnosed in 1978-1981...
Estimated incidence and prevalence of female breast cancer in Italian regionsA Micheli
Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Tumori 78:13-21. 1992..In 1987, about 250,000 Italian women had a present or past history of breast cancer: for the 1970-1987 period, prevalence has increased by approximately 5,500 cases per year...
The prevalence of tumors of the breast and female genital tract in ItalyM Sant
Epidemiology Division, National Cancer Institute (INT, Milan, Italy
Tumori 85:382-6. 1999..The prevalence of corpus uteri cancer decreased slightly in the elderly only, whereas that of cervix uteri cancer decreased at all ages...
Incident lung cancer survival. Long-term follow-up of a population-based study in ItalyU Pastorino
Department of Thoracic Surgery (OCT, National Cancer Institute, Milan, Italy
Tumori 76:199-204. 1990....
Breast cancer prevalence measured by the Lombardy Cancer RegistryA Micheli
Division of Epidemiology, National Cancer Institute, Milan, Italy
Tumori 83:875-9. 1997..CONCLUSION: Owing to aging of the population, the improvement in survival and the increasing incidence, the number of prevalent cases will increase. This phenomenon has and will have great importance for the health planning...
Cancer survival in five continents: a worldwide population-based study (CONCORD)Michel P Coleman
Cancer Research UK Cancer Survival Group, Non communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, UK
Lancet Oncol 9:730-56. 2008..This is, to our knowledge, the first worldwide analysis of cancer survival, with standard quality-control procedures and identical analytic methods for all datasets...
MeningiomaChristine Marosi
University of Vienna, Austria
Crit Rev Oncol Hematol 67:153-71. 2008..Hormonal therapy with progesterone antagonists has shown modest results, while chemotherapy with hydroxyurea appears moderately active...
Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th centuryRiccardo Capocaccia
National Centre for Epidemiology, Surveillance and Health Promotion, Department of Cancer Epidemiology, Istituto Superiore di Sanita, Rome, Italy
Am J Gastroenterol 102:1661-70; quiz 1660, 1671. 2007..We compared population-based liver cancer incidence and survival in European and U.S. populations in order to elucidate geographic differences and time trends for these variables...
